Concepedia

Maria V. Filsinger Interrante

MV

3

Publications

61

Citations

3

H-Index

2021

Active since

Affiliations

Stanford University(Current)

Duke Medical Center

Chan Zuckerberg Initiative (United States)

Maria V. Filsinger Interrante is an author at Stanford University specializing in toll-like receptors, vaccine development, and allergy.

ORCID

Top concepts

Publications per year

2021–2024

3

Publications

3

The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat

David C. Montefiori, Maria V. Filsinger Interrante, Benjamin N. Bell et al. · Proceedings of the National Academy of Sciences · 2021 · 26 citations · Full text

Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses

Ben S. Ou, Julie Baillet, Maria V. Filsinger Interrante et al. · Science Advances · 2024 · 21 citations · Full text

, , +22

A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity

Adonis A. Rubio, Maria V. Filsinger Interrante, Benjamin N. Bell et al. · Journal of Virology · 2021 · 14 citations · Full text

Rows per page

1–3 of 3